Fenofibrate is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease. Like other fibrates,it reduces both lowdensity lipoprotein (LDL) and very low density lipoprotein (VLDL) levels,as well as increasing highdensity lipoprotein (HDL) levels and reducing triglycerides level. It is used alone or along with statins in the treatment of hypercholesterolemia and hypertriglyceridemia.
Fenofibrate, marketed as Tricor and under several other brand names, is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in people at risk of cardiovascular disease. Like other fibrates, it reduces both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, as well as increasing high-density lipoprotein(HDL) levels and reducing triglyceride levels. It is used alone or along with statins in the treatment ofhypercholesterolemia and hypertriglyceridemia.
Fenofibrate is mainly used for primary hypercholesterolemia or mixed dyslipidemia. Fenofibrate appears to decrease the risk of cardiovascular disease and possibly diabetic retinopathy in those with diabetes mellitus, and firstly indicated for the reduction in the progression of diabetic retinopathy in patients with type 2 diabetes and existing diabetic retinopathy in Australia. It also appears to be helpful in decreasing amputations of the lower legs in this same group of people. Fenofibrate also has an off-label use as an added therapy of high blood uric acid levels in people who have gout.
Loaʻa iā mākou nā hale hana kiʻekiʻe me ka pilina hohonu, hiki iā ia ke hāʻawi iā ʻoe i nā huahana kiʻekiʻe a me nā kumukūʻai hoʻokūkū. A hiki iā mākou ke hāʻawi i nā uku no nā kūʻai nui. A ke hui pū nei mākou me nā ʻoihana lawe ukana ʻoihana he nui, hiki ke hāʻawi i nā huahana me ka palekana a me ka maʻalahi i kou mau lima. ʻO ka manawa hoʻouna ma kahi o 3-20 mau lā ma hope o ka hōʻoia ʻana o ka uku.
Items | Standards | Results | |
Ka nana aku | White or off-white powder | Off-white powder | |
Identification | By HPLC | Hoʻokō | |
Lae hehee | 120ºC~130ºC | 126ºC | |
Nalo ma ka maloo | ≤1.00% | 0.21% | |
Heavy Metals | ≤ 10ppm | Hoʻokō | |
Sulfated Ash | ≤ 0.10% | 0.03% | |
Chlorine Content | 17.5%~19.5% | 19.3% | |
Arsenic Content | ≤ 0.1ppm | 0.09ppm | |
Lead VContent | ≤ 3.0ppm | 0.50ppm | |
Cadmium Content | ≤ 0.1ppm | 0.10ppm | |
Mercury Content | ≤ 0.1ppm | 0.10ppm | |
Microbiological Test | Coliforms:Negative | ʻinoʻino | |
Salmonella: Negative | Hoʻokō | ||
Total plate count: ≤1000 CFU/g | Pass | ||
Yeast&Mold: ≤50 CFU/g | Pass | ||
Related Substances | Impurity A: ≤0.30% | 0.18% | |
Other unknown impurity: ≤0.10% | 0.07% | ||
Total Impurities: ≤0.50% | 0.42% | ||
Assay | ≥ 98.0% | 99.50% | |
Reference Standard | USP Kūlana |
1. He hale hana ʻoe a he hui kālepa paha?
He compnay mākou e hoʻohui i ka ʻoihana a me ke kālepa, e hāʻawi ana i ka lawelawe hoʻokahi. Hiki ke ʻae ʻia ʻo OEM.
2. Hāʻawi anei ʻoe i nā laʻana? He manuahi a keu paha?
Free samples.The sample's freight fee Pono e uku ma kou aoao.
3. Loaʻa iā ʻoe nā palapala hōʻoia e pili ana i ka mana maikaʻi?
ISO 9001: 2008 palapala hōʻoia e hōʻoia i ka maikaʻi.
4. He aha kaʻu e hāʻawi ai e kiʻi i kahi ʻōlelo?
E haʻi mai ʻo Pls iā mākou i ke ʻano huahana āu e pono ai, ka nui o ke kauoha, ka helu a me nā koi kikoʻī. E hana ʻia ka ʻōlelo no kāu kuhikuhi i ka manawa.
5. He aha ke ʻano o ka uku uku āu e makemake ai? He aha ke ʻano o nā ʻōlelo i ʻae ʻia?
ʻAe ʻia nā ʻōlelo hoʻouna: FOB, CFR, CIF, EXW;
Accepted Payment Currency:USD;EUR
ʻAno uku i ʻae ʻia: T / T, Western Union; Paypal, Hōʻoia Kūʻai.
ʻŌlelo i ʻōlelo ʻia: English.
Māhele huahana